These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24773705)

  • 1. Examining the incremental impact of long-standing health conditions on subjective well-being alongside the EQ-5D.
    Wu M; Brazier J; Relton C; Cooper C; Smith C; Blackburn J
    Health Qual Life Outcomes; 2014 Apr; 12():61. PubMed ID: 24773705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample.
    Wu M; Brazier JE; Kearns B; Relton C; Smith C; Cooper CL
    Eur J Health Econ; 2015 Mar; 16(2):141-51. PubMed ID: 24408476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context.
    Petrou S; Morrell J; Spiby H
    Health Qual Life Outcomes; 2009 May; 7():40. PubMed ID: 19419553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
    Torrance N; Lawson KD; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH
    Pain; 2014 Oct; 155(10):1996-2004. PubMed ID: 25020004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.
    Nikl A; Janssen MF; Jenei B; Brodszky V; Rencz F
    Pharmacoeconomics; 2024 May; 42(5):583-603. PubMed ID: 38416366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative importance of the EQ-5D five dimensions among patients with chronic diseases in South Korea - a comparison with the general population preference weights.
    Hong J
    Health Qual Life Outcomes; 2018 Aug; 16(1):159. PubMed ID: 30075726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
    Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
    Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
    Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a difference between EQ-5D and SF-6D in the clinical setting? a comparative study on the quality of life measured by AIMS2-SF, EQ-5D and SF-6D scales for osteoarthritis patients.
    Zhang F; Yang Y; Huang T; Zhang Y; Zhao L; Li S
    Int J Rheum Dis; 2018 Jun; 21(6):1185-1192. PubMed ID: 27463704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filling the psycho-social gap in the EQ-5D: the empirical support for four bolt-on dimensions.
    Chen G; Olsen JA
    Qual Life Res; 2020 Nov; 29(11):3119-3129. PubMed ID: 32648198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures.
    Brazier J; Connell J; Papaioannou D; Mukuria C; Mulhern B; Peasgood T; Jones ML; Paisley S; O'Cathain A; Barkham M; Knapp M; Byford S; Gilbody S; Parry G
    Health Technol Assess; 2014 May; 18(34):vii-viii, xiii-xxv, 1-188. PubMed ID: 24857402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?
    Tinelli M; Ryan M; Bond C; Scott A
    Pharmacoeconomics; 2013 Feb; 31(2):163-71. PubMed ID: 23329427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
    Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J
    Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normative Profile of Health-Related Quality of Life for Hong Kong General Population Using Preference-Based Instrument EQ-5D-5L.
    Wong EL; Cheung AW; Wong AY; Xu RH; Ramos-Goñi JM; Rivero-Arias O
    Value Health; 2019 Aug; 22(8):916-924. PubMed ID: 31426933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
    Park SJ; Ahn S; Woo SJ; Park KH
    JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases.
    Sakthong P; Munpan W
    Appl Health Econ Health Policy; 2017 Oct; 15(5):669-679. PubMed ID: 28290106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.